Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00388544 · ClinicalTrials.gov registry record · Phase 2
Enhancing Quality of Life for Nursing Home Residents
A Phase 2 study of Alzheimers Disease, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT00388544 is a Phase 2 study of Alzheimers Disease that has completed, run by Penn State University. The registered enrollment target is 128 participants, below the 4,060-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00388544, a Phase 2 study of Alzheimers Disease, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
Many persons with dementia exhibit behaviors that caregivers find difficult to manage. The purpose of this study is to test the effectiveness of individualized recreational activities for reducing agitation and passivity in persons with dementia.
Conditions Studied
Interventions
- BEHAVIORAL Activity matched to interest
- BEHAVIORAL Activity matched to function
- BEHAVIORAL Activity matched to both interest and function
Study Locations (1)
Pennsylvania
- Nursing homes in Central and Northeast Pennsylvania - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00388544
The ClinicalTrials.gov registry entry for NCT00388544 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,060-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (97% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 3 interventions - of which Activity matched to interest is the first listed.
NCT00388544 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00388544 about?
NCT00388544 is a clinical study titled "Enhancing Quality of Life for Nursing Home Residents". Many persons with dementia exhibit behaviors that caregivers find difficult to manage. The purpose of this study is to test the effectiveness of individualized recreational activities for reducing agitation and passivity in persons with dementia.
What is the current status of trial NCT00388544?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2005-05. Estimated completion is 2010-02.
What conditions does trial NCT00388544 study?
This clinical trial studies the following conditions: Alzheimers Disease.
What interventions are being tested in trial NCT00388544?
The interventions under investigation include: Activity matched to interest (BEHAVIORAL), Activity matched to function (BEHAVIORAL), Activity matched to both interest and function (BEHAVIORAL).
Who is sponsoring clinical trial NCT00388544?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00388544 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
RECRUITING · Phase 2
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
Open-label Extension Study in Participants With Early Alzheimer's Disease
RECRUITING · Phase 2
-
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RECRUITING · Phase 2
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.